Cas No.: 1260223-44-6
PRODUCT INFORMATION
Description
CGGRGD is a cysteine-terminated RGD derivative synthesized via solid-phase peptide synthesis (SPPS). As a fibronectin-mimetic peptide, it demonstrates selective αvβ3 integrin binding, making it a tool for research into targeted molecular delivery and the development of molecular imaging probes. Its terminal cysteine allows for conjugation, and the TFA salt formulation optimizes stability for research.
Molecular Weight
563.59
Purity
> 95%
Formula
C₁₉H₃₃N₉O₉S
Product Type
Targeting Peptide
Sequence
Cys-Gly-Gly-Arg-Gly-Asp
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- HER2-targeted Peptide H6F (CAT#: OLY-1025-YS-5)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- LyP-2 Targeting Peptide (CAT#: OLY-1025-YS-65)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.